Literature DB >> 18174639

Clinico-laboratory profile of pediatric HIV in Karnataka.

Ramesh R Pol1, T A Shepur, Vinod H Ratageri.   

Abstract

OBJECTIVE: To study the clinical manifestations and incidence of opportunistic infections in HIV/AIDS seropositive proven hospitalized children.
METHODS: Proven HIV seropositive children aged between 18 months to 12 years, admitted between April 2004 to June 2005 (15 months) to pediatric medical ward, KIMS, Hubli, were enrolled. Socio-demographic characteristics and clinical manifestations were recorded in the predesigned proforma. A complete physical examination and laboratory investigations were performed at the time of admission. Children were categorized as per 1994 revised CDC classification of pediatric HIV infection.
RESULTS: Number of HIV seropositive children admitted during study period was 71. Vertical transmission was noted in 94.37%, which is the major route of transmission. The common symptoms noted were persistent fever (70.42%), persistent cough (59.15%), loss of appetite (59.15%), loss of weight (56.33%) and recurrent diarrhea (30.99%). The common signs present were, hepatomegaly (69.04%), skin lesions (59.15%), lymphadenopathy (57.75%) and severe malnutrition (54.93%). The common opportunistic infections observed were tuberculosis (38.03%), recurrent diarrhea (30.99%), oral candidiasis (21.13%) and recurrent bacterial pneumonia (12.68%). Six (8.45%) children died during the study period, which included 4 (5.63%) cases of HIV-encephalopathy.
CONCLUSION: Vertical transmission was the major route of HIV infection. Persistent fever, cough, loss of appetite and loss of weight were common presenting clinical features. Tuberculosis was the commonest opportunistic infection.

Entities:  

Mesh:

Year:  2007        PMID: 18174639     DOI: 10.1007/s12098-007-0199-3

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  13 in total

1.  Seropositivity rate for HIV infection in hospitalized children on selective screening.

Authors:  M Agrawal; G V Koppikar; R Ghildiyal; M Chavarkar; S M Joshi; K R Lahiri
Journal:  Indian Pediatr       Date:  2001-03       Impact factor: 1.411

Review 2.  Human immunodeficiency virus infection.

Authors:  S Singh
Journal:  Indian Pediatr       Date:  2000-12       Impact factor: 1.411

3.  Clinical manifestations of HIV-1 infection.

Authors:  Valsan Philip Verghese; Thomas Cherian; Anil J Cherian; P George Babu; T Jacob John; Chellam Kirubakaran; P Raghupathy
Journal:  Indian Pediatr       Date:  2002-01       Impact factor: 1.411

Review 4.  AIDS in the Americas: a public health priority for the region.

Authors:  T C Quinn; J P Narain; F R Zacarias
Journal:  AIDS       Date:  1990-08       Impact factor: 4.177

5.  Ocular and systemic lesions in children with HIV.

Authors:  J Biswas; A A Kumar; A E George; H N Madhavan; N Kumarasamy; S N Mothi; S Solomon
Journal:  Indian J Pediatr       Date:  2000-10       Impact factor: 1.967

6.  Clinical profile of pediatric HIV infection from India.

Authors:  Shilpa R Shah; Milind S Tullu; Jaishree R Kamat
Journal:  Arch Med Res       Date:  2005 Jan-Feb       Impact factor: 2.235

7.  Clinical profile of HIV infection.

Authors:  R H Merchant; J S Oswal; R V Bhagwat; J Karkare
Journal:  Indian Pediatr       Date:  2001-03       Impact factor: 1.411

8.  Clinical spectrum of HIV infection.

Authors:  R Dhurat; M Manglani; R Sharma; N K Shah
Journal:  Indian Pediatr       Date:  2000-08       Impact factor: 1.411

9.  Clinically directed selective screening for HIV infection in hospitalized children.

Authors:  Sandeep B Bavdekar; Rinku Agarwal
Journal:  Indian Pediatr       Date:  2005-12       Impact factor: 1.411

10.  Clinical manifestations of HIV infected children.

Authors:  Purnima Madhivanan; S N Mothi; N Kumarasamy; T Yepthomi; C Venkatesan; John S Lambert; Suniti Solomon
Journal:  Indian J Pediatr       Date:  2003-08       Impact factor: 5.319

View more
  8 in total

1.  Longevity on Antiretroviral Therapy for Children Living with HIV/AIDS--A Price to Pay for Success?

Authors:  Mamatha M Lala; Rashid H Merchant
Journal:  Indian J Pediatr       Date:  2016-02-06       Impact factor: 1.967

2.  Clinico-Immunological Profile of Children Infected with HIV Through Vertical Transmission, in Southern India.

Authors:  Praveen R Shahapur; Indira Bairy
Journal:  J Clin Diagn Res       Date:  2014-06-20

3.  Duration of hospitalization and appetite of HIV-infected South African children.

Authors:  Siyazi Mda; Joop M A van Raaij; Una E MacIntyre; François P R de Villiers; Frans J Kok
Journal:  Matern Child Nutr       Date:  2011-04       Impact factor: 3.092

4.  Profiles of HIV-infected anti-retroviral therapy naïve children from Mumbai, India.

Authors:  Supriya Mayur Paranjpe; Purva Pankaj Sarkate; Nayana Avinash Ingole; Shweta Sadanand Raut; Preeti Rajeev Mehta
Journal:  World J Pediatr       Date:  2016-06-10       Impact factor: 2.764

5.  Health & nutritional status of HIV infected children in Hyderabad, India.

Authors:  G Krishna Swetha; R Hemalatha; U V Prasad; Vasudev Murali; K Damayanti; V Bhaskar
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

6.  Associated oral lesions in human immunodefeciency virus infected children of age 1 to 14 years in anti retroviral therapy centers in Tamil Nadu.

Authors:  R Krishna Kumar; G Mohan; N Venugopal Reddy; V Arun Prasad Rao; M Shameer; Ananthi Christopher
Journal:  Contemp Clin Dent       Date:  2013-10

7.  Factors affecting adherence to treatment in children living with HIV.

Authors:  Deepshikha Verma; Damodar Bachani; Anita Shankar Acharya; Anju Seth; Alok Hemal
Journal:  Indian J Sex Transm Dis AIDS       Date:  2020-07-31

8.  Factors associated with mortality due to neonatal pneumonia in India: a protocol for systematic review and planned meta-analysis.

Authors:  N Sreekumaran Nair; Leslie Edward Lewis; Theophilus Lakiang; Myron Godinho; Shruti Murthy; Bhumika T Venkatesh
Journal:  BMJ Open       Date:  2017-09-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.